Form 4: Oncocyte Corp Director Acquires 90,219 Shares in Open Market Transaction

Patrick W. Smith, a director at Oncocyte Corp, purchased 90,219 shares of common stock at a price of $2.13 per share on December 26, 2024.

Summary

• On December 26, 2024, Patrick W. Smith, a director of Oncocyte Corp, acquired 90,219 shares of the company's common stock.
• The shares were purchased at a price of $2.13 per share.
• Following this transaction, Mr. Smith's total beneficial ownership increased to 1,773,903 shares.
• The shares are held indirectly through The Smith Irrevocable Trust, of which Mr. Smith is the trustee.

Sentiment

Score: 6

Explanation: The document is a neutral disclosure of a stock purchase by a director. It is neither particularly positive nor negative, but the purchase could be interpreted as a sign of confidence.

Positives

• A director's purchase of shares can be seen as a positive signal of confidence in the company's future prospects.
• The purchase increases the director's stake in the company, aligning his interests with those of other shareholders.

Industry Context

This is a routine disclosure of insider trading activity, which is common in publicly traded companies. It does not indicate any specific trend in the biotechnology industry.

Comparison to Industry Standards

• Insider trading disclosures are a standard practice for all publicly listed companies, including those in the biotechnology sector.
• The transaction is similar to other Form 4 filings by directors and officers of comparable companies such as Exact Sciences (EXAS) or Guardant Health (GH), where they report their purchases or sales of company stock.
• The size of the transaction is not unusual for a director's purchase, and the price is consistent with the market price at the time of the transaction.

Stakeholder Impact

• The purchase may have a slightly positive impact on shareholder sentiment, as it indicates a director's confidence in the company.

Key Dates

Keywords

Oncocyte Corp, insider trading, stock purchase, beneficial ownership, Patrick W. Smith, director, OCX